Mira Pharmaceuticals, Common Stock Today
| MIRA Stock | 1.02 0.08 7.27% |
PerformanceVery Weak
| Odds Of DistressAbove Average
|
MIRA Pharmaceuticals, is trading at 1.02 as of the 26th of February 2025, a 7.27 percent decrease since the beginning of the trading day. The stock's open price was 1.1. MIRA Pharmaceuticals, has over 56 % chance of experiencing financial distress in the next 2 years of operation and has generated negative returns for investors over the last 90 days. The performance scores are derived for the period starting the 28th of November 2024 and ending today, the 26th of February 2025. Click here to learn more.
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
MIRA Stock Highlights
| CEO Director | Erez Aminov |
| Thematic Idea | Pharmaceutical Products (View all Themes) |
| Old Name | Mirada Plc |
| Business Concentration | Pharmaceuticals, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Jakarta Stock Exchange, NASDAQ Composite, NASDAQ Health Care, Pharmaceutical Products, Health Care, Pharmaceuticals, Biotechnology, Healthcare (View all Sectors) |
| Financial Strength | |
MIRA Pharmaceuticals, Common (MIRA) is traded on NASDAQ Exchange in USA. It is located in 1200 Brickell Avenue, Miami, FL, United States, 32183 and employs 5 people. MIRA Pharmaceuticals, is listed under Pharmaceuticals category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a current market capitalization of 16.89 M. MIRA Pharmaceuticals, conducts business under Pharmaceuticals sector and is part of Health Care industry. The entity has 16.56 M outstanding shares of which 583.89 K shares are now shorted by private and institutional investors with about 1.65 trading days to cover.
MIRA Pharmaceuticals, generates negative cash flow from operations
Check MIRA Pharmaceuticals, Probability Of Bankruptcy
Ownership AllocationMIRA Pharmaceuticals, maintains a total of 16.56 Million outstanding shares. MIRA Pharmaceuticals, Common holds noticeable amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check MIRA Ownership Details
MIRA Pharmaceuticals, Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. MIRA Pharmaceuticals, market risk premium is the additional return an investor will receive from holding MIRA Pharmaceuticals, long position in a well-diversified portfolio.
| Risk Adjusted Performance | (0.03) | |||
| Jensen Alpha | (0.26) | |||
| Total Risk Alpha | (0.29) | |||
| Treynor Ratio | (1.05) |
MIRA Stock Against Markets
MIRA Pharmaceuticals, Corporate Executives
Elected by the shareholders, the MIRA Pharmaceuticals,'s board of directors comprises two types of representatives: MIRA Pharmaceuticals, inside directors who are chosen from within the company, and outside directors, selected externally and held independent of MIRA. The board's role is to monitor MIRA Pharmaceuticals,'s management team and ensure that shareholders' interests are well served. MIRA Pharmaceuticals,'s inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, MIRA Pharmaceuticals,'s outside directors are responsible for providing unbiased perspectives on the board's policies.
| Michelle MBA | Secretary CFO | Profile |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in MIRA Pharmaceuticals, Common. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of MIRA Pharmaceuticals,. If investors know MIRA will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about MIRA Pharmaceuticals, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of MIRA Pharmaceuticals, is measured differently than its book value, which is the value of MIRA that is recorded on the company's balance sheet. Investors also form their own opinion of MIRA Pharmaceuticals,'s value that differs from its market value or its book value, called intrinsic value, which is MIRA Pharmaceuticals,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because MIRA Pharmaceuticals,'s market value can be influenced by many factors that don't directly affect MIRA Pharmaceuticals,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between MIRA Pharmaceuticals,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if MIRA Pharmaceuticals, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, MIRA Pharmaceuticals,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.